EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease

EphA2 receptor tyrosine kinase (RTK) is highly expressed in breast tumor cells across multiple molecular subtypes and correlates with poor patient prognosis. In this study, the potential role of EphA2 in this clinically relevant phenomenon is investigated as metastasis of breast cancer to bone is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaught, David B, Merkel, Alyssa R, Lynch, Conor C, Edwards, James, Tantawy, Mohammed Noor, Hilliard, Timothy, Wang, Shan, Peterson, Todd, Johnson, Rachelle W, Sterling, Julie A, Brantley‐Sieders, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046157/
https://www.ncbi.nlm.nih.gov/pubmed/33869989
http://dx.doi.org/10.1002/jbm4.10465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046157/
https://www.ncbi.nlm.nih.gov/pubmed/33869989
http://dx.doi.org/10.1002/jbm4.10465

Ejemplares similares